Location History:
- Manchester, GB (2020 - 2023)
- Macclesfield, GB (2022 - 2023)
Company Filing History:
Years Active: 2020-2023
Title: Innovations by Rebecca Newton in Cancer Research
Introduction
Rebecca Newton is a prominent inventor based in Manchester, GB. She has made significant contributions to the field of cancer research, holding a total of six patents. Her work focuses on developing compounds that inhibit RET kinase activity, which is crucial in the treatment of various proliferative disorders, including cancer.
Latest Patents
Rebecca's latest patents include innovative compounds that serve as RET inhibitors. The first patent describes compounds of formula I that function as inhibitors of the RET kinase enzyme activity. These compounds are essential in the preparation of pharmaceutical compositions aimed at treating diseases where RET kinase activity is implicated. The second patent also relates to heterocyclic compounds that act as RET kinase inhibitors, further emphasizing her commitment to advancing cancer treatment.
Career Highlights
Rebecca Newton works at Cancer Research Technology Limited, where she applies her expertise in developing therapeutic solutions. Her dedication to research and innovation has positioned her as a key figure in the fight against cancer.
Collaborations
Rebecca collaborates with notable colleagues, including Allan Michael Jordan and Bohdan Waszkowycz. Their combined efforts contribute to the advancement of cancer research and the development of effective treatments.
Conclusion
Rebecca Newton's work exemplifies the impact of innovation in the medical field, particularly in cancer research. Her patents and collaborations highlight her commitment to improving patient outcomes through scientific advancements.